Ignite Creation Date:
2024-05-06 @ 6:47 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05780840
Status:
RECRUITING
Last Update Posted:
2023-03-23
First Post:
2023-02-22
Brief Title:
Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria
Sponsor:
Bispebjerg Hospital
Organization:
Bispebjerg Hospital
Study Overview
Official Title:
Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria
Status:
RECRUITING
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
What is the visible light protective effect of dihydroxyacetone in individuals with erythropoietic protoporphyria This will be tested in this randomized blinded placebo controlled study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None